Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stona is a brand of over-the-counter (OTC) multi-symptom cold, flu, and cough remedies developed and marketed by Sato Pharmaceutical. The Stona product line includes various formulations tailored to specific cold symptoms, such as nasal congestion, sore throat, fever, and cough. Common active ingredients across the Stona line include acetaminophen (for pain and fever relief), dextromethorphan hydrobromide (cough suppressant), chlorpheniramine maleate (antihistamine), phenylephrine hydrochloride (nasal decongestant), and guaifenesin (expectorant). These products are widely available in Japan and other Asian markets in tablet, capsule, and liquid gel formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Stona.